What to Make of the GLP-1 Coverage and Cost Landscape
How are payers handling the rise of GLP-1s? Cost and clinical transparency can support whatever strategy a plan takes.
What to Make of the GLP-1 Coverage and Cost Landscape Read More »
RxSS Member Support – Savings and Satisfaction in One Call or Click
RxSS member support comes from pharmacy technicians who go all out to find affordable prescriptions and deliver peace of mind.
RxSS Member Support – Savings and Satisfaction in One Call or Click Read More »
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus
Up to 10 competing products for Humira are on the way in 2023. What should health plans and plan sponsors be following as the biosimilars landscape takes shape?
The Great 2023 Humira Biosimilars Watch Is On – Here’s Where to Focus Read More »
A Q&A on the IRA
The Inflation Reduction Act has the potential to lower prescription drug costs for millions of Americans and raise them for millions more. Who stands to gain or lose?
Let’s Talk About Mental Health
Every May we raise awareness about mental health as we continue to help our members stay adherent by showing them affordable options for the medications they need.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor
Many point benefits solutions have produced positive results for employers and health plans. However, their full potential depends on medication access and affordability.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor Read More »
Personalized Healthcare Evolves Around Partnerships
For 20 years, the promised future of personalized healthcare seemed elusive. Not anymore, thanks to innovative partners who are driving better outcomes.
Personalized Healthcare Evolves Around Partnerships Read More »
Flip the Script – Bryan S., PharmD
Trends and timely topics from the PharmD’s who give Rx Savings Solutions our unmatched clinical clout. Meet Bryan Schuessler, Director of Specialty Rx.
Delays or Not, Employers Should Still Prep for Transparency in Coverage
Despite enforcement delays, group health plans should keep moving toward price transparency. They have more to gain than compliance.
Delays or Not, Employers Should Still Prep for Transparency in Coverage Read More »
Infamous Combo-Drug Now Has a Generic Available
Generics are a no-brainer for cost savings, right? No such thing in pharmacy. Generic Duexis¨ just hit the market, with a price tag that’s still higher 20 times higher than a simple alternative.